BRIDGET CONKLIN: Open Payments
NPI 1679589808 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 32 payments from 13 companies in 2025. Trend: 2023 $838 · 2024 $652 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $258 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Janssen Biotech, Inc. | 2 | $48 |
| TOLMAR, INC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $28 |
| Novo Nordisk Inc | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
Products named: GEMTESA, ORGOVYX, VERQUVO, ERLEADA, JARDIANCE, LifeVest, Wegovy, JATENZO.
Industry payments across PA — which companies pay providers there.
